« previous next »
Pages: [1]

Author Topic: Ofatumumab  (Read 534 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
Update on ofatumumab (OMB157)
« on: January 21, 2020, 09:32:23 pm »
An update on ofatumumab--from Nasdaq.com (January 21, 2020), "Novartis gets approval for MS drug Mayzent in Europe." (The article contains information about ofatumumab.)


https://www.nasdaq.com/articles/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe-2020-01-21
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
37 Views 		Last post December 03, 2020, 04:32:12 pm
by agate
0 Replies
39 Views 		Last post October 25, 2022, 09:20:47 pm
by agate